Questions discussed in this category
How do you choose between CAR-T and autoSCT, for example?
Does this differ for a patient who had a longer remission before relapse?
Given the results of ZUMA-7, TRANSFORM, and BELINDA - how does this inform your current practice? What are the currently approved indications for CAR-...
CAR-T (any specific preference of product?) vs bispecific antibodies vs any other specific agents not previously utilized?
Do you limit it to post-pubertal patients? Do you offer it only if they will proceed with bone marrow transplantation after CAR-T?
15458139571391970865033134141287312698115571068691687034
Papers discussed in this category
N Engl J Med, 2021 Dec 11
Lancet,
Blood, 2020 Sep 23
International journal of radiation oncology, biology, physics, 2019-12-01
The Lancet. Oncology, 2019-01
Molecular therapy : the journal of the American Society of Gene Therapy, 2018-11-07
Cancer immunology research, 2019-07
Br J Haematol, 2020 Mar 5
Lancet, 2020 Sep 01
Blood Adv,
Int J Radiat Oncol Biol Phys, 2020 May 22
J Clin Oncol, 2021 Dec 9
Blood Cancer Discov, 2021 Dec 01
Proc Natl Acad Sci U S A, 2019 Apr 15
N Engl J Med,
Exp Hematol Oncol, 2021 Feb 19
Blood, 2022 Mar 03